Serum soluble vascular cell adhesion molecule-1 overexpression is a disease marker in patients with first-time diagnosed antinuclear antibodies: a prospective, observational pilot study (sVCAM-1 in ANA-positive patients) First published 04/01/2018 Last updated 31/03/2024 EU PAS number:EUPAS22154 Study Finalised